BIOFINITY XR
FDA premarket approval P080011/S024 · decided 2013-07-16
Approval details
- PMA number
- P080011
- Supplement
- S024
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- BIOFINITY XR
- Generic name
- Lenses, soft contact, extended wear
- Applicant
- CooperVision, Inc.
- Date received
- 2013-05-13
- Decision date
- 2013-07-16
- Days to decision
- 64 days
- Decision code
- APPR
- Product code
- LPM
- Advisory committee
- Ophthalmic
- Expedited review
- No
- Location
- San Ramon, CA
- Statement
- APPROVAL TO ADD THE NEW BRAND NAME BIOFINITY XR.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.